Bariatric embolization for suppression of the hunger hormone ghrelin in a porcine model

Radiology

Volumn 266, Issue 2, 2013, Pages 471-479

  Paxton, Ben E ^a   Kim, Charles Y ^a   Alley, Christopher L ^a   Crow, Jennifer H ^a   Balmadrid, Bryan ^b   Keith, Christopher G ^a   Kankotia, Ravi J ^a   Stinnett, Sandra ^a   Arepally, Aravind ^c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c Division of Interventional Radiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GLUCOSE; MICROSPHERE;

ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL EMBOLISM; BARIATRIC EMBOLIZATION; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; HORMONE BLOOD LEVEL; HORMONE INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH FUNDUS; SWINE; WEIGHT GAIN; WILCOXON SIGNED RANKS TEST;

ANIMALS; CASE-CONTROL STUDIES; EMBOLIZATION, THERAPEUTIC; GHRELIN; MICROSPHERES; OBESITY; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; STOMACH; SWINE;

EID: 84873385659     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12120242     Document Type: Article

References (34)

1. Druce MR, Small CJ, Bloom SR. Minireview: gut peptides regulating satiety. Endocrinology 2004;145(6):2660-2665.
2. Strader AD, Woods SC. Gastrointestinal hormones and food intake. Gastroenterology 2005;128(1):175-191.
3. Inui A, Asakawa A, Bowers CY, et al. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J 2004;18(3):439-456.
4. Hayashida T, Murakami K, Mogi K, et al. Ghrelin in domestic animals: distribution in stomach and its possible role. Domest Anim Endocrinol 2001;21(1):17-24.
5. Takiguchi S, Adachi S, Yamamoto K, et al. Mapping analysis of ghrelin producing cells in the human stomach associated with chronic gastritis and early cancers. Dig Dis Sci 2012;57(5):1238-1246.
6. Maksud FA, Alves JS, Diniz MT, Barbosa AJ. Density of ghrelin-producing cells is higher in the gastric mucosa of morbidly obese patients. Eur J Endocrinol 2011;165(1):57-62.
7. Cummings DE, Shannon MH. Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? J Clin Endocrinol Metab 2003;88(7):2999-3002.
8. Hu Z, Cha SH, Van Haasteren G, Wang J, Lane MD. Effect of centrally administered C75, a fatty acid synthase inhibitor, on ghrelin secretion and its downstream effects. Proc Natl Acad Sci U S A 2005;102(11):3972-3977.
9. Murray CD, Kamm MA, Bloom SR, Emmanuel AV. Ghrelin for the gastroenterologist: history and potential. Gastroenterology 2003;125(5):1492- 1502.
10. Loftus TM, Jaworsky DE, Frehywot GL, et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 2000;288(5475):2379-2381.
11. Wren AM, Small CJ, Abbott CR, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001;50(11):2540-2547.
12. Arepally A, Barnett BP, Montgomery E, Patel TH. Catheter-directed gastric artery chemical embolization for modulation of systemic ghrelin levels in a porcine model: initial experience. Radiology 2007;244(1):138-143.
13. Arepally A, Barnett BP, Patel TH, et al. Catheter-directed gastric artery chemical embolization suppresses systemic ghrelin levels in porcine model. Radiology 2008;249(1):127-133.
14. Spurlock ME, Gabler NK. The development of porcine models of obesity and the metabolic syndrome. J Nutr 2008;138(2):397-402.
15. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growthhormone-releasing acylated peptide from stomach. Nature 1999;402(6762):656-660.
16. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001;50(8):1714-1719.
17. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature 2001;409(6817):194-198.
18. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002;346(21):1623-1630.
19. Frühbeck G, Diez Caballero A, Gil MJ. Fundus functionality and ghrelin concentrations after bariatric surgery. N Engl J Med 2004;350(3):308-309.
20. Tritos NA, Mun E, Bertkau A, Grayson R, Maratos-Flier E, Goldfne A. Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Obes Res 2003;11(8):919-924.
21. Goldfne AB, Shoelson SE, Aguirre V. Expansion and contraction: treating diabetes with bariatric surgery. Nat Med 2009;15(6):616-617.
22. Chuang VP, Reuter SR. Selective arterial embolization for the control of traumatic splenic bleeding. Invest Radiol 1975;10(1):18-24.
23. Padia SA, Geisinger MA, Newman JS, Pierce G, Obuchowski NA, Sands MJ. Effectiveness of coil embolization in angiographically detectable versus non-detectable sources of upper gastrointestinal hemorrhage. J Vasc Interv Radiol 2009;20(4):461-466.
24. Rösch J, Keller FS, Kozak B, Niles N, Dotter CT. Gelfoam powder embolization of the left gastric artery in treatment of massive smallvessel gastric bleeding. Radiology 1984;151(2):365-370.
25. Lee HJ, Shin JH, Yoon HK, et al. Transcatheter arterial embolization in gastric cancer patients with acute bleeding. Eur Radiol 2009;19(4):960-965.
26. Larsen MO, Rolin B. Use of the Göttingen minipig as a model of diabetes, with special focus on type 1 diabetes research. ILAR J 2004;45(3):303-313.
27. Sumithran P, Prendergast LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 2011;365(17):1597-1604.
28. Beckman LM, Beckman TR, Earthman CP. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. J Am Diet Assoc 2010;110(4):571-584.
29. Beckman LM, Beckman TR, Sibley SD, et al. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery. JPEN J Parenter Enteral Nutr 2011;35(2):169-180.
30. Perboni S, Inui A. Appetite and gastrointestinal motility: role of ghrelin-family peptides. Clin Nutr 2010;29(2):227-234.
31. Connor P. Gastric pacing. DOC News 2005;2(2):18.
32. Cigaina V. Long-term follow-up of gastric stimulation for obesity: the Mestre 8-year experience. Obes Surg 2004;14(Suppl 1):S14-S22.
33. Hanusch-Enserer U, Cauza E, Brabant G, et al. Plasma ghrelin in obesity before and after weight loss after laparoscopical adjustable gastric banding. J Clin Endocrinol Metab 2004;89(7):3352-3358.
34. Leonetti F, Silecchia G, Iacobellis G, et al. Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. J Clin Endocrinol Metab 2003;88(9):4227-4231.